These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 25996682)

  • 1. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
    Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
    Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
    Qu X; Othus M; Davison J; Wu Y; Yan L; Meshinchi S; Ostronoff F; Estey EH; Radich JP; Erba HP; Appelbaum FR; Fang M
    Cancer; 2017 Jul; 123(13):2472-2481. PubMed ID: 28222251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
    Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
    Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of methylation profiling to identify significant differentially methylated genes in bone marrow mesenchymal stromal cells from acute myeloid leukemia.
    Huang J; Liu Z; Sun Y; Zhong Q; Xu L; Ou R; Li C; Chen R; Yao M; Zhang Q; Liu S
    Int J Mol Med; 2018 Feb; 41(2):679-686. PubMed ID: 29207054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer.
    Wu Y; Davison J; Qu X; Morrissey C; Storer B; Brown L; Vessella R; Nelson P; Fang M
    Epigenetics; 2016 Apr; 11(4):247-58. PubMed ID: 26890304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Region-Specific Methylation Profiling in Acute Myeloid Leukemia.
    Cecotka A; Polanska J
    Interdiscip Sci; 2018 Mar; 10(1):33-42. PubMed ID: 29405013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.
    Zhou JD; Zhang TJ; Wang YX; Yang DQ; Yang L; Ma JC; Wen XM; Yang J; Lin J; Qian J
    Tumour Biol; 2016 Jul; 37(7):8951-60. PubMed ID: 26753961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.
    Akalin A; Garrett-Bakelman FE; Kormaksson M; Busuttil J; Zhang L; Khrebtukova I; Milne TA; Huang Y; Biswas D; Hess JL; Allis CD; Roeder RG; Valk PJ; Löwenberg B; Delwel R; Fernandez HF; Paietta E; Tallman MS; Schroth GP; Mason CE; Melnick A; Figueroa ME
    PLoS Genet; 2012; 8(6):e1002781. PubMed ID: 22737091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association.
    Gebhard C; Glatz D; Schwarzfischer L; Wimmer J; Stasik S; Nuetzel M; Heudobler D; Andreesen R; Ehninger G; Thiede C; Rehli M
    Leukemia; 2019 Jan; 33(1):26-36. PubMed ID: 29925905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
    Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
    Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.
    Zhao X; Tian X; Kajigaya S; Cantilena CR; Strickland S; Savani BN; Mohan S; Feng X; Keyvanfar K; Dunavin N; Townsley DM; Dumitriu B; Battiwalla M; Rezvani K; Young NS; Barrett AJ; Ito S
    Br J Haematol; 2016 Nov; 175(3):427-439. PubMed ID: 27433923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
    Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
    Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of distinctive long noncoding RNA competitive interactions and a six-methylated-gene prognostic signature in acute myeloid leukemia with -5/del(5q) or -7/del(7q).
    Yin X; Huang S; Xu A; Fan F; Chen L; Sun C; Hu Y
    J Cell Biochem; 2020 Feb; 121(2):1563-1574. PubMed ID: 31535409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
    Szankasi P; Ho AK; Bahler DW; Efimova O; Kelley TW
    Leuk Res; 2011 Feb; 35(2):200-7. PubMed ID: 20970189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of TFPI-2 gene and its promoter methylation in acute myeloid leukemia].
    Shao LL; Fan J; Wang R; Feng LL; Zhen CQ; Sui XH; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):920-6. PubMed ID: 25130804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats.
    Saied MH; Marzec J; Khalid S; Smith P; Down TA; Rakyan VK; Molloy G; Raghavan M; Debernardi S; Young BD
    PLoS One; 2012; 7(3):e33213. PubMed ID: 22479372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemia.
    Roux B; Picou F; Debeissat C; Koubi M; Gallay N; Hirsch P; Ravalet N; Béné MC; Maigre M; Hunault M; Mosser J; Etcheverry A; Gyan E; Delhommeau F; Domenech J; Herault O
    Cancer Gene Ther; 2022 Aug; 29(8-9):1263-1275. PubMed ID: 35194200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Array-based DNA methylation profiling in acute myeloid leukaemia.
    Wilop S; Fernandez AF; Jost E; Herman JG; Brümmendorf TH; Esteller M; Galm O
    Br J Haematol; 2011 Oct; 155(1):65-72. PubMed ID: 21790528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.